INBS Intelligent Bio: Aggregate Business Assets

The development of fingerprint-based diagnostic systems is protected by exclusive patents, which, combined with regulatory certifications, create significant barriers to entry for competitors. This chart of share prices on GURU.Markets demonstrates total assets at 10.27. Intelligent Bio Solutions (INBS) maintains high brand status due to the creation of ultra-fast non-invasive tests, while competent management is currently actively expanding sales within the industrial security segment.

ibs.inc (INBS) Company Total Assets: for the period 04/28/2023 - 10/27/2026

Financial and market metric breakdowns for ibs.inc (INBS)

- price and consensus price forecast:

Market Chart Intelligent Bio Solutions Inc.|INBS - Consensus Target

- market capitalization data:

Market Value INBS|INBS - Enterprise Value

- book capitalization data:

Accounting Value of a Share Intelligent Bio Solutions|INBS - Book Capitalization|Market-to-Book Ratio ibs.inc|INBS - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio Intelligent Bio Solutions|INBS - Long-Term Debt to Capital|Short-Term Debt to Capital Intelligent Bio Solutions Inc.|INBS - Company Debts|Debts to Book Capitalization Ratio INBS

Fundamental company analysis:Intelligent Bio Solutions

For Intelligent Bio Solutions, the aggregate of resources is critically important, as the capitalization of patents for biometric testing systems determines business resilience under stringent FDA and CE regulations. By analyzing the total asset forecast, calculated reverse-engineered via ROA as the sum of liabilities and equity, the investor assesses the company's actual material base to avoid overpaying for inflated growth expectations.

Competing companies

Company Total Asset Base dexcom.com|Penumbra (PEN) - Cumulative Company Assets|Aggregate Business Assets Novanta Inc|Haemonetics Corp. (HAE) - Company Total Assets|Aggregate Asset Value Inspire Medical Systems Inc (INSP)|PRCT: Company Total Assets|conmed.com - Company Assets|Aggregate Company Assets Pulse Biosciences (PLSE)|INMD - Aggregate Asset Value|PMI: Company Total Assets|SRDX (Surmodics Inc.) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc SENS|Total Asset Value of Company neuropace.com|Tactile Systems Technology - Company Total Assets|Company Assets SANUWAVE Health SNWV|Cumulative Company Assets OM (Outset)|ELMD - Company Total Assets|Cumulative Company Assets LENSAR, Inc. LNSR|RCEL - Aggregate Business Assets|profoundmedical.com - Company Total Assets|Baird Medical (BDMD) - Company Total Asset Base|Company Total Assets EDAP|Cumulative Company Assets Bovie Medical (APYX)|IceCure Medical Ltd (ICCM) - Cumulative Company Assets|Aggregate Asset Value LUNG (pulmonx.com)|TELA Bio - Aggregate Company Assets|Cumulative Company Assets CytoSorbents Corp CTSO|SRTS (Sensus Healthcare Corp) - Company Total Assets|ZYXI - Company Assets|Company Total Assets electrocore.com|Vicarious Surgical (RBOT) - Total Business Assets|IINN: Company Total Assets|Company Total Asset Base SeaStar Medical Holding Corporation|Company Total Assets IRIX (IRIDEX Corporation)|Cumulative Company Assets beyondair.net (XAIR)|Company Total Assets PFSA (Profusa Inc)|STRATA Skin Sciences Inc. - Company Total Assets|GCTK - Aggregate Company Assets|nanovibronix.com (NAOV) - Aggregate Company Assets|Cumulative Company Assets Venus Concept Corp VERO|Nuwellis Corp (NUWE) - Aggregate Asset Value|Company Total Assets AEMD (Aethlon Medical)|Company Assets ASXC|AVGR: Aggregate Company Assets|Company Balance Sheet Assets BioSig Technologies BSGM|Cumulative Company Assets CUTR (Cutera, Inc)|Company Total Assets Know Labs Corporation KNW|Company Total Assets NARI (Inari Medical, Inc.)|NVRO: Company Total Asset Base|Aggregate Company Assets reshapelifesciences.com (RSLS)|SILK (Silk Road Medical, Inc.) - Total Asset Value of Company